Conferences - Results from #8640

SUO 2017: Penile Cancer – Introduction and Discussion of New 2018 Staging November 30, 2017

SUO 2017: Optimal Timing of Adjuvant and Salvage Radiation Following Radical Prostatectomy November 30, 2017

SUO 2017: Using Genomic Biomarkers to Select Patients for Postoperative Therapies for Prostate Cancer November 30, 2017

SUO 2017: Genomics and Molecular Testing after Radical Prostatectomy November 30, 2017

SUO 2017: Muscle-invasive Bladder Cancer Patients Who Did Not Receive Radical Cystectomy: Treatment Decisions, Alternative Treatments, And Opportunities For Care Improvement November 30, 2017

SUO 2017: Trials, Trends, and Models: Synthesizing the Evidence on Prostate Cancer Screening November 30, 2017

SUO 2017: When First Line Chemotherapy Fails - Locally Advanced or Metastatic Penile Cancer Patient November 30, 2017

SUO 2017: Immunotherapy of Genitourinary Cancer: Renal Cell Carcinoma – Emerging Data for Locally Advanced and Metastatic Disease November 30, 2017

SUO 2017: From Biopsy, AS vs Rx: Stratifying Risk in Localized PCa November 30, 2017

SUO 2017: Currently Approved Immunotherapy for Bladder Cancer November 30, 2017

SUO 2017: Stratifying Risk in Localized Prostate Cancer November 30, 2017

SUO 2017: Complications Following Radical Cystectomy And Urinary Diversion Surgery November 30, 2017

SUO 2017: Cancer And All-cause Mortality In Bladder Cancer Patients Undergoing Radical Cystectomy: Development And Validation Of A Nomogram For Treatment Decision-making November 30, 2017

SUO 2017: Novel Use Of Pre-operative CT-measured Adipose Tissue Indices To Predict Postoperative And Survival Outcomes Among Patients Undergoing Radical Cystectomy November 30, 2017

SUO 2017: Clinical Utility of Next Generation Sequencing in Urothelial Bladder Cancer November 30, 2017

SUO 2017: Bladder Cancer: Comparative Analysis of National Cancer Database with Propensity Score Weighting November 30, 2017

SUO 2017: Cost-effectiveness Analysis Of A Biomarker-based Approach To Select Patients With Muscle-invasive Bladder Cancer For Neoadjuvant Chemotherapy November 30, 2017

SUO 2017: Effect of Blue-Light Cystoscopy of Recurrence/Progression Rates for Vesigenurtacel-L (Hs-410) with BCG in Patients with NMIBC November 30, 2017

SUO 2017: Assessment of Blue Light Flexible Cystoscopy with Cysview on Patient Reported Outcomes November 30, 2017

SUO 2017: Prostate Cancer Anxiety in Men Undergoing Active Surveillance November 30, 2017

Page 433 of 594